Corvus is a unique environment for exceptional individuals who want to learn, contribute to an exceptional team, and make a difference in the lives of people with cancer. At Corvus, we take pride in our collaborative, community-based culture. We understand that the most successful teams are those that learn from each other and co-create in an environment that nurtures open, transparent communication.
View Top Employees from Corvus PharmaceuticalsWebsite | http://www.corvuspharma.com |
Ticker | CRVS |
Revenue | $9.5 million |
Funding | $244.3 million |
Employees | 38 (38 on RocketReach) |
Founded | 2014 |
Address | 863 Mitten Road Suite 102, Burlingame, California 94010, US |
Phone | (650) 900-4520 |
Technologies |
JavaScript,
HTML,
Google Analytics
+7 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Biopharma, Drug Discovery, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Corvus Pharmaceuticals employee's phone or email?
The Corvus Pharmaceuticals annual revenue was $9.5 million in 2024.
Daniel Hunt is the Senior Vice President Chief Business and Legal Officer of Corvus Pharmaceuticals.
38 people are employed at Corvus Pharmaceuticals.
Corvus Pharmaceuticals is based in Burlingame, California.
The NAICS codes for Corvus Pharmaceuticals are [32, 3254, 32541, 325].
The SIC codes for Corvus Pharmaceuticals are [28, 283].